About 4 million Americans got updated COVID vaccines in September
By Ahmed Aboulenein and Michael Erman (Reuters) -Around 4 million Americans received the…
N2:MRCH
US govt awards $1.4 billion for development of new COVID therapies,…
(Reuters) - The U.S. government said on Tuesday it had awarded $1.4 billion for the…
Moderna’s updated COVID vaccine effective against…
(Reuters) - Moderna said on Thursday an initial study data showed its updated COVID-19…
AbbVie trims forecast for Humira sales drop on favorable coverage
By Leroy Leo and Patrick Wingrove (Reuters) -AbbVie on Thursday trimmed its 2023 view for…
J&J upbeat on 2023 as devices rebound post-COVID, shares jump
By Bhanvi Satija and Patrick Wingrove (Reuters) -Johnson & Johnson on Thursday…
Acumen’s Alzheimer’s drug passes initial safety test
By Julie Steenhuysen CHICAGO (Reuters) - An experimental Alzheimer's disease drug…
US FTC seeks additional info on Pfizer’s proposed takeover of…
(Reuters) -The US Federal Trade Commission (FTC) has sought additional information and…
US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug
By Deena Beasley and Julie Steenhuysen LOS ANGELES (Reuters) -Eisai and Biogen's…
Wall Street slips as investors eye Russia, Fed hikes, quarter-end
By Sinéad Carew, Sruthi Shankar and Johann M Cherian (Reuters) - U.S. stocks closed lower…
Pfizer to raise $31 billion for Seagen takeover in largest debt…
(Reuters) -Pfizer Inc is planning to raise $31 billion through its largest debt offering…